The selling price or list price of a medical device is driven by numerous factors, such as therapy area and complexity of procedure, level of reimbursement, development costs, the number of competing manufacturers, product life cycle, and whether there have been any recent new technology or product launches.

In addition, the final selling pricing of medical devices is also impacted by the discounting policy of the manufacturer. Companies such as Stryker apply discounts for their devices based on their internal business strategy, inventory control, and monthly or quarterly sales targets. In addition, sale location can also affect the final selling price of a device, both in terms of geographical region and facility type. Prices for the same medical device often vary in hospitals and health systems versus outside of hospital facilities, for example if high volume healthcare institutions can negotiate discounts or rebates based on large purchase sizes.

Stryker overview

Stryker Corp (Stryker) is a medical technology company which is engaged in manufacturing of an array of orthopedic, medical and surgical, and neurotechnology and spine products and allied services. Its major products include orthopedic implants; surgical equipment and surgical navigation systems; patient handling, emergency medical equipment and intensive care disposable products; endoscopic and communications systems. It also offers neurosurgical equipments, neurovascular and spinal devices; and medical devices for use in a variety of conditions. Stryker offers products to doctors, hospitals and other healthcare facilities. The company sells its products through subsidiaries, branches, third-party dealers, and distributors in the Americas, Europe, Asia-Pacific, the Middle East and Africa. Stryker is headquartered in Kalamazoo, Michigan, the US.

For a complete picture of ACCOLADE PLUS, Hip Reconstruction pricing in the US, buy the report here.